• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention.

作者信息

Eustace Ian

机构信息

Liverpool Centre for Cardiovascular Science, Liverpool John Moores University and Liverpool Heart and Chest Hospital, University of Liverpool, Liverpool, UK.

School of Nursing and Advanced Practice, Liverpool John Moores University, Liverpool, UK.

出版信息

Cerebrovasc Dis Extra. 2024;14(1):101-104. doi: 10.1159/000540805. Epub 2024 Aug 12.

DOI:10.1159/000540805
PMID:39134009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11521491/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb6/11521491/e47dfe180c7f/cee-2024-0014-0001-540805_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb6/11521491/e47dfe180c7f/cee-2024-0014-0001-540805_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbb6/11521491/e47dfe180c7f/cee-2024-0014-0001-540805_F01.jpg

相似文献

1
Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention.抗凝治疗依从性：弥合急性卒中治疗与长期二级预防之间的差距
Cerebrovasc Dis Extra. 2024;14(1):101-104. doi: 10.1159/000540805. Epub 2024 Aug 12.
2
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.口服抗凝剂依从性对心房颤动患者中风风险和大出血的影响。
J Am Heart Assoc. 2016 Feb 23;5(2):e003074. doi: 10.1161/JAHA.115.003074.
3
Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.心房颤动患者口服抗凝治疗的依从性。聚焦于非维生素K拮抗剂口服抗凝药。
Thromb Haemost. 2017 Jan 26;117(2):209-218. doi: 10.1160/TH16-10-0757. Epub 2016 Nov 10.
4
Anticoagulation Choice and Timing in Stroke Due to Atrial Fibrillation: A Survey of US Stroke Specialists (ACT-SAFe).抗凝治疗选择和时机：房颤相关性卒中美国卒中专家调查（ACT-SAFe）
J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105169. doi: 10.1016/j.jstrokecerebrovasdis.2020.105169. Epub 2020 Jul 31.
5
Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.房颤患者卒中预防中优化口服抗凝治疗所面临的挑战综述。
Am J Cardiovasc Drugs. 2013 Apr;13(2):87-102. doi: 10.1007/s40256-013-0016-5.
6
Adherence to oral anticoagulation in secondary stroke prevention--the first year of direct oral anticoagulants.二级卒中预防中口服抗凝治疗的依从性——直接口服抗凝剂的第一年
J Stroke Cerebrovasc Dis. 2015 Jan;24(1):78-82. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.032. Epub 2014 Oct 16.
7
Personalizing oral anticoagulant treatment in patients with atrial fibrillation.心房颤动患者口服抗凝治疗的个体化
Expert Rev Cardiovasc Ther. 2013 Aug;11(8):959-73. doi: 10.1586/14779072.2013.818819. Epub 2013 Aug 19.
8
Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.伴有房颤的缺血性脑卒中患者接受紧急再灌注治疗时的抗凝安全性。
Stroke. 2020 Aug;51(8):2347-2354. doi: 10.1161/STROKEAHA.120.030143. Epub 2020 Jul 10.
9
Confidence in the Use of Direct Oral Anticoagulants in the Acute Phase of Nonvalvular Atrial Fibrillation-Related Ischemic Stroke Over the Years: A Real-World Single-Center Study.多年来非瓣膜性心房颤动相关缺血性卒中急性期使用直接口服抗凝剂的信心：一项真实世界单中心研究
J Stroke Cerebrovasc Dis. 2018 Jan;27(1):76-82. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.001. Epub 2017 Sep 13.
10
[Anticoagulation and new therapeutic options in atrial fibrillation].[心房颤动的抗凝治疗及新的治疗选择]
Dtsch Med Wochenschr. 2016 Oct;141(22):1618-1623. doi: 10.1055/s-0042-113075. Epub 2016 Nov 4.

本文引用的文献

1
Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation.心房颤动患者卒中单元出院后抗凝治疗依从性的预测因素
Cerebrovasc Dis Extra. 2024 Feb 12;14(1):21-9. doi: 10.1159/000537781.
2
Effect of Previous INR Control during VKA Therapy on Subsequent DOAC Adherence and Persistence, in Patients Switched from VKA to DOAC.华法林治疗期间既往 INR 控制对接受华法林转换为 DOAC 治疗的患者随后 DOAC 依从性和持续性的影响。
Thromb Haemost. 2024 Aug;124(8):778-790. doi: 10.1055/a-2168-9378. Epub 2023 Sep 6.
3
Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharmacy: A Meta-analysis.
口服抗凝剂对合并多种药物治疗的心房颤动患者的影响：一项荟萃分析。
Thromb Haemost. 2025 Feb;125(2):166-177. doi: 10.1055/s-0043-1770724. Epub 2023 Jul 3.
4
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.华法林与非维生素 K 拮抗剂口服抗凝剂在房颤患者中的有效性和安全性。
Thromb Haemost. 2024 Feb;124(2):135-148. doi: 10.1055/s-0043-1769735. Epub 2023 Jun 27.
5
Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动患者的口服抗凝药物剂量分析和治疗依从性。
JAMA Netw Open. 2023 Jun 1;6(6):e2317156. doi: 10.1001/jamanetworkopen.2023.17156.
6
Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study.心房颤动患者口服抗凝药的依从性和持续性：一项比利时全国队列研究。
Front Cardiovasc Med. 2022 Sep 29;9:994085. doi: 10.3389/fcvm.2022.994085. eCollection 2022.
7
Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III.心房颤动患者的临床复杂性领域、抗凝治疗与结局：GLORIA-AF 注册研究 II 期和 III 期报告。
Thromb Haemost. 2022 Dec;122(12):2030-2041. doi: 10.1055/s-0042-1756355. Epub 2022 Aug 29.
8
Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation.依从性是最大限度提高房颤患者口服抗凝药物有效和安全使用的最佳因素。
Sci Rep. 2022 Mar 1;12(1):3413. doi: 10.1038/s41598-022-07316-y.
9
Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany.房颤患者中每日一次与每日两次直接口服抗凝剂的依从性和持续性：来自荷兰、意大利和德国的真实世界分析。
Drugs Real World Outcomes. 2022 Jun;9(2):199-209. doi: 10.1007/s40801-021-00289-w. Epub 2022 Jan 6.
10
Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015).非瓣膜性心房颤动患者对直接口服抗凝剂的依从性：六个欧洲国家的跨国比较（2008 - 2015年）
Front Pharmacol. 2021 Nov 3;12:682890. doi: 10.3389/fphar.2021.682890. eCollection 2021.